bullish
Dividend HealthCare Stocks Screener – Jan 2022
SUMMARY
- It’s a volatile market these days! The Omicron variant, interest rate hikes, supply chain disruption, and labor shortage are causing the market to fluctuate wildly
- Healthcare companies provide essential services regardless of economic conditions.
- The screener results were quite satisfactory. AbbVie, Amgen, and Merck. I like all of them!
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- AbbVie (ABBV US): Q3 Sales Miss as Humira OUS Declines; 2022 Guidance Narrowed; Dividend Raised29 Oct 2022
- AbbVie (ABBV US): Mixed Q1 Show; 2022 Guidance Trimmed; Stock Price Reaction Seems Overdone30 Apr 2022
- AbbVie Inc (ABBV US): Great Value Stock to Buy in Choppy Market23 Mar 2022
- Dividend HealthCare Stocks Screener – Jan 202201 Mar 2022
x